510(k) Report

510(k) · Cleared

Cleared

Xpan Universal Trocar System

K223562510(k) TraditionalCleared Jun 2, 2023186-day reviewClass II21 CFR 876.1500

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Xpan, Inc. · GCJ Laparoscope, General & Plastic Surgery

Cleared on Jun 2, 2023 as substantially equivalent to K012539 (United States Surgical, A Division of Tyco Healthc, 2001) after a 186-day review. Its family tree reaches back 3 generations to 1994.

Decided
Jun 2, 2023
Review
186 days
Class
Class II
Product code
GCJ
Recalls
None
Predicates
1

Its longest line of descent runs back 3 generations to K940232 (1994). 7 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 3 generations backK940232 Innerdyne Step Trocar Expandable Port, S.T.E.P.Innerdyne Medical, Inc. · 1994
  2. 2 generations backK961940 Innerdyne Step Trocar Expandable Port, OnestepInnerdyne, Inc. · 1996 · Recalled
  3. 1 generation backK012539 VerastepUnited States Surgical, A Division of Tyco Healthc · 2001
  4. This deviceK223562 Xpan Universal Trocar SystemXpan, Inc. · 2023
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K940232Innerdyne Step Trocar Expandable Port, S.T.E.P.Innerdyne Medical, Inc.1994—
−2K961940Innerdyne Step Trocar Expandable Port, OnestepInnerdyne, Inc.19961
−1K012539VerastepUnited States Surgical, A Division of Tyco Healthc2001—
0 (this device)K223562Xpan Universal Trocar SystemXpan, Inc.2023—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199410
199530
FIG. 1 — Lineage of K223562, 1994–2023Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GCJ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GCJ device

  1. #1 K214046 780 nm 1688 4K Camera System, 780 nm L11 LED…score 21.4 · 21 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K012539Verastep
Summary page 4
…500 Review Panel General and Plastic Surgery Predicate Device: Proprietary/Trade VersaStep™ Bladeless Trocar Name 510(k) Number K012539 Common or Usual Name Surgical Trocar Classification Name Endoscope and Accessories Regulatory Class Cla…
United States Surgical, A Division of Tyco Healthc2001—
†K982472Genicon TrocarGenicon, LC199915
†K112349Versaport V2 Bladeless Optiical Trocar and/or Versaport Bladeless Optical TrocarCovidien, Formerly US Surgical A Divison of Tyco H20116
†K130435Versaport V2 Bladeless Optical TrocarCovidien, Formerly US Surgical A Divison of Tyco H2013—

Also cleared against K012539: 4 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 29 years and passes through 4 companies; a new generation was cleared every 5.2 years on median.
  • 1 of the 7 ancestors has a recall of any class.
  • 4 other devices also cite its predicate K012539.

How does its category compare?

All GCJ devices

GCJ Laparoscope, General & Plastic Surgery: FDA decisions, review times, recalls and adverse event reports over 20 years. 2023, this device’s year, is highlighted.

FDA decisions per year · GCJ

21in 2025

2007: 182008: 192009: 212010: 242011: 152012: 172013: 152014: 192015: 262016: 272017: 202018: 212019: 152020: 282021: 182022: 202023: 312024: 292025: 212026 (partial year): 26
2007high 31 (2023) · low 15 (2011)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GCJ

108in 2025

2007: 42 days median2008: 73 days median2009: 85 days median2010: 122 days median2011: 113 days median2012: 88 days median2013: 93 days median2014: 90 days median2015: 76 days median2016: 99 days median2017: 77 days median2018: 88 days median2019: 60 days median2020: 61 days median2021: 116 days median2022: 103 days median2023: 109 days median2024: 90 days median2025: 108 days median2026 (partial year): 122 days median
2007high 122 (2010) · low 42 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · GCJ

5in 2025

2007: 122008: 162009: 62010: 302011: 92012: 12013: 7, 1 Class I2014: 22016: 52017: 12018: 12022: 12023: 12025: 52026 (partial year): 1
2007high 30 (2010) · low 0 (2015)2026

Class I (1 since 2007) Class II/III not classified

Adverse event reports per year · GCJ

5,860in 2025

2007: 1,6392008: 1,3192009: 1,9952010: 2,6572011: 2,1332012: 1,5262013: 1,5652014: 1,7142015: 1,7102016: 2,0802017: 3,4682018: 2,5622019: 2,5782020: 2,6182021: 3,4312022: 3,9452023: 6,0022024: 6,0472025: 5,860
2007high 6,047 (2024) · low 1,319 (2008)2025

MAUDE reports naming product code GCJ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071842121,639
20081973161,319
2009218561,995
201024122302,657
20111511392,133
2012178811,526
201315937 (1)1,565
2014199021,714
2015267601,710
2016279952,080
2017207713,468
2018218812,562
2019156002,578
2020286102,618
20211811603,431
20222010313,945
20233110916,002
2024299006,047
20252110855,860
2026261221—

What is it indicated for?

The Xpan Universal Trocar System is intended to provide dilation access with or without visualization to the abdominal and thoracic cavities for performing diagnostic and operative abdominal and thoracic procedures.

Laparoscopic access to the abdominal cavity, both primary and secondary punctures.

Thoracoscopic access to the thoracic cavity, both primary and secondary punctures.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K223562: Xpan Universal Trocar System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K223562

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026